- Home
- MIND vs AVTX Comparison
MIND vs AVTX Comparison
Compare MIND & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIND
- AVTX
- Stock Information
- Founded
- MIND 1987
- AVTX 2011
- Country
- MIND United States
- AVTX United States
- Employees
- MIND N/A
- AVTX N/A
- Industry
- MIND Industrial Machinery/Components
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- MIND Industrials
- AVTX Health Care
- Exchange
- MIND Nasdaq
- AVTX Nasdaq
- Market Cap
- MIND 53.6M
- AVTX 57.4M
- IPO Year
- MIND 1994
- AVTX 2015
- Fundamental
- Price
- MIND $6.71
- AVTX $4.73
- Analyst Decision
- MIND
- AVTX Strong Buy
- Analyst Count
- MIND 0
- AVTX 7
- Target Price
- MIND N/A
- AVTX $31.00
- AVG Volume (30 Days)
- MIND 228.7K
- AVTX 89.2K
- Earning Date
- MIND 06-10-2025
- AVTX 08-11-2025
- Dividend Yield
- MIND N/A
- AVTX N/A
- EPS Growth
- MIND N/A
- AVTX N/A
- EPS
- MIND 2.91
- AVTX N/A
- Revenue
- MIND $45,087,000.00
- AVTX $441,000.00
- Revenue This Year
- MIND $7.28
- AVTX N/A
- Revenue Next Year
- MIND N/A
- AVTX N/A
- P/E Ratio
- MIND $2.27
- AVTX $0.69
- Revenue Growth
- MIND 26.68
- AVTX N/A
- 52 Week Low
- MIND $3.05
- AVTX $3.39
- 52 Week High
- MIND $11.10
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- MIND 46.58
- AVTX 57.87
- Support Level
- MIND $5.88
- AVTX $4.46
- Resistance Level
- MIND $6.34
- AVTX $4.90
- Average True Range (ATR)
- MIND 0.39
- AVTX 0.37
- MACD
- MIND -0.05
- AVTX 0.09
- Stochastic Oscillator
- MIND 37.57
- AVTX 88.61
About MIND MIND Technology Inc. (DE)
MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; China, Norway; Turkey; Singapore; and Canada & Other.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).